Trials / Completed
CompletedNCT01802775
Edoxaban in Peripheral Arterial Disease
A Randomized, Open-Label, Parallel-Group, Multi-Center Study Of Adding Edoxaban Or Clopidogrel To Aspirin To Maintain Patency In Subjects With Peripheral Arterial Disease Following Femoropopliteal Endovascular Intervention
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized, open-label, blinded endpoint, parallel-group, active-control, multi-center, proof-of-concept study in subjects with Peripheral Arterial Disease (PAD), designed to assess the safety and potential efficacy of adding edoxaban to aspirin following femoropopliteal endovascular intervention, with or without stent placement, relative to current treatment practice with clopidogrel and aspirin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | edoxaban | |
| DRUG | Clopidogrel | 75mg tablet |
| DRUG | Aspirin |
Timeline
- Start date
- 2013-02-06
- Primary completion
- 2014-12-03
- Completion
- 2014-12-03
- First posted
- 2013-03-01
- Last updated
- 2019-02-26
- Results posted
- 2018-01-12
Locations
42 sites across 7 countries: United States, Austria, Belgium, Germany, Israel, Netherlands, Switzerland
Source: ClinicalTrials.gov record NCT01802775. Inclusion in this directory is not an endorsement.